UPDATE 1-FDA approves Celgene's bone marrow cancer treatment
August 16, 2019 at 10:25 AM EDT
The U.S. Food and Drug Administration on Friday approved Celgene Corp's Inrebic to treat certain rare forms of bone marrow cancer called myelofibrosis.